A surge in the stock prices of companies developing COVID-19 vaccines, treatments and testing kits has minted at least one new billionaire and boosted the fortunes of nine members of the three-comma-club.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...